doxazosin has been researched along with Heart Diseases in 4 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment of benign prostatic hyperplasia (BPH) with nonselective alpha1 antagonists such as terazosin, doxazosin, and prazosin results in blood pressure reduction due to vasodilation." | 3.71 | Initiation of nonselective alpha1-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia: a retrospective cohort study. ( Chao, J; Chrischilles, E; Gilden, D; Kreder, KJ; Rubenstein, L; Shah, H, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pulcrano, M | 1 |
Palmieri, EA | 1 |
Pagano, L | 1 |
Tauchmanova, L | 1 |
Rossi, A | 1 |
Fazio, S | 1 |
Lombardi, G | 1 |
Biondi, B | 1 |
Margolis, KL | 1 |
Piller, LB | 1 |
Ford, CE | 1 |
Henriquez, MA | 1 |
Cushman, WC | 1 |
Einhorn, PT | 1 |
Colon, PJ | 1 |
Vidt, DG | 1 |
Christian, R | 1 |
Wong, ND | 1 |
Wright, JT | 1 |
Goff, DC | 1 |
Gokel, Y | 1 |
Dokur, M | 1 |
Paydaş, S | 1 |
Chrischilles, E | 1 |
Rubenstein, L | 1 |
Chao, J | 1 |
Kreder, KJ | 1 |
Gilden, D | 1 |
Shah, H | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
[NCT00000542] | Phase 3 | 0 participants | Interventional | 1993-08-31 | Completed | ||
The Effects of Systemic Alfuzosin and Tamsulosin Hydrochloride on Choroidal Thickness and Pupil Diameter Sizes in Cases With Benign Prostatic Hyperplasia[NCT03144596] | Phase 4 | 63 participants (Actual) | Interventional | 2015-10-29 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for doxazosin and Heart Diseases
Article | Year |
---|---|
Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Black People; Blood Pressure; Canada; Chlorthal | 2007 |
3 other studies available for doxazosin and Heart Diseases
Article | Year |
---|---|
Long-term efficacy of doxazosin plus atenolol in the management of severe and sustained arterial hypertension and reversibility of the cardiac damage induced by chronic cathecolamine excess. A case report in a young girl with recurrent, functioning paraga
Topics: 3-Iodobenzylguanidine; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Atenolol; Blood Pr | 2004 |
Doxazosin overdosage.
Topics: Adrenergic alpha-Antagonists; Adult; Doxazosin; Heart Diseases; Humans; Male | 2000 |
Initiation of nonselective alpha1-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia: a retrospective cohort study.
Topics: Accidental Falls; Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Cohort Studies; Comor | 2001 |